Metabolic Dysfunction 1 Associated

Apuntes

Metabolic Dysfunction – Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association https://doi.org/10.2337/dci24-0094 Kenneth Cusi, 1 Manal F. Abdelmalek, 2 Caroline M. Apovian, 3 Kirthikaa Balapattabi, 4 Raveendhara R. Bannuru, 4 Diana Barb, 1 Joan K. Bardsley, 5 Elizabeth A. Beverly, 6,7 Karen D. Corbin, 8 Nuha A. ElSayed, 4,9 Scott Isaacs, 10 Fasiha Kanwal, 11 Elizabeth J. Pekas, 4 Caroline R. Richardson, 12 Michael Roden, 13,14,15 Arun J. Sanyal, 16 Jay H. Shubrook, 17 Zobair M. Younossi, 18,19 and Mandeep Bajaj 11 Metabolic dysfunction – associated steatotic liver disease (MASLD), formerly re- ferred to as nonalcoholic fatty liver disease (NAFLD), is a growing but often unrec- ognized medical problem for people with diabetes (particularly type 2 diabetes, especially when associated with obesity). Liver health has not been at the fore- front of complications tracked for disease prevention, as traditionally done for di- abetic retinopathy, nephropathy, or neuropathy. However, liver steatosis affects approximately two out of three people with type 2 diabetes and places ...